Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Get CLEATUSFree Trial

Get CLEATUSFree Trial

Search

Top

Back to Contracts

Preclinical Biomedical Research on Traumatic Orthopaedic Injuries

Active

Grant

Response Deadline11/18/2026, 05:00:00 AM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This contract requires the conduct of preclinical biomedical research focused on bone healing, tissue regeneration, and orthopaedic trauma models using animal systems, with the goal of advancing medical solutions aligned with military needs. The work involves designing controlled experiments, collecting longitudinal data on injury response and recovery, and performing rigorous statistical and biological analysis to evaluate therapeutic interventions. All research must be tailored to simulate combat-related orthopaedic injuries and produce actionable insights applicable to field medical care and soldier recovery protocols. The effort is structured as a subcontract under the Department of the Army through USAMRAA, with a solicitation posted on June 17, 2026, and a response deadline of November 18, 2026. The project falls under NAICS code 541711 for research and development in the physical, engineering, and life sciences. Performance location and point of contact details are not specified, but the research must be executed in facilities capable of supporting high-standard animal modeling and biomechanical analysis. The ultimate objective is to generate validated preclinical data to inform the development of next-generation treatments for traumatic injuries sustained in military operations.

General Info

Preclinical bone healing and trauma research using animal models for military medical advancements.

Agency

Department Of Defense → Department Of The Army -- UsamraaView Agency

NAICS

541711 - Research and Development in BiotechnologyView NAICS

Place of Performance

Not specified

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedJun 17

subcontract

Response DeadlineNov 18

Submission deadline

Response Deadline

11/18/2026, 05:00:00 AM UTCin 4 months

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Defense → Department Of The Army -- Usamraa

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Defense → Department Of The Army -- Usamraa

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

Conduct preclinical studies on bone healing, tissue regeneration, and orthopaedic trauma models using animal systems. Includes experimental design, data collection, and analysis aligned with military medical needs.

Similar Contracts

Same NAICS industry code

Phase 2/3 Clinical Trial ExecutionThe contract pertains to the execution of Phase 2/3 clinical trials focused on acute pain management, requiring full management of trial operations including site selection, patient recruitment, data collection, and safety monitoring in strict compliance with FDA regulations. The work will be performed in Frederick, Maryland, with a post date of June 29, 2026, and a response deadline of July 30, 2026, at 5:00 PM. This is a subcontract under the Defense Health Agency, part of the Department of Defense, and falls under NAICS code 541711 for research and development in the physical, engineering, and life sciences. All activities must adhere to regulatory standards to ensure trial integrity, patient safety, and data reliability, with performance centered in Frederick, MD.

Defense Health Agency

POSTED

DEADLINE

Preclinical Animal Studies for Neurofibromatosis ResearchThe contract seeks to conduct preclinical in vivo studies using genetically engineered mouse models or alternative animal models of neurofibromatosis to assess the efficacy of therapeutic interventions, track tumor progression, and investigate underlying biological mechanisms. The work requires advanced expertise in animal modeling, tumor biology, and preclinical drug evaluation, with a focus on generating robust, reproducible data to support future clinical translation. All studies must be conducted in accordance with established ethical and scientific standards for animal research, with detailed documentation of methodologies, outcomes, and adverse events. This subcontract is issued under the Defense Health Agency Contracting Activity and falls under NAICS code 541711, indicating it supports research and development in the physical, engineering, and life sciences. The solicitation was posted on June 25, 2026, with a response deadline of September 22, 2026, and is open to qualified entities capable of executing complex preclinical studies. While the place of performance and point of contact details are unspecified, successful proposers must demonstrate capacity to manage animal facilities, comply with regulatory requirements, and deliver high-quality, timely results in support of neurofibromatosis research objectives under the Department of Defense.

Defense Health Agency Contracting Activity - Dhaca

POSTED

about 1 month ago

DEADLINE

in about 2 months

Collaborative Biomedical Research ExecutionThis contract enables a collaborative biomedical research effort focused on neurofibromatosis, requiring coordinated hypothesis-driven investigations led by an Initiating Principal Investigator and a Partnering Principal Investigator. The work encompasses the design of experiments, generation of empirical data, and rigorous milestone-based progress reporting to ensure scientific rigor and accountability. The project is structured as a subcontract under the Defense Health Agency Contracting Activity, falling under the NAICS code for research and development in the physical, engineering, and life sciences, and is intended to advance understanding of neurofibromatosis through integrated scientific contributions. The solicitation was posted on June 25, 2026, with a response deadline of September 22, 2026, and is managed by the Department of Defense through its health research infrastructure. While no set-aside provisions or specific location details are provided, the emphasis is firmly on outcome-driven research with clearly defined deliverables tied to research milestones. The effort requires close alignment between the two principal investigators to ensure cohesive experimental planning, data integrity, and timely reporting, reflecting a strategic investment in translational medical science with potential implications for defense-relevant health conditions.

Defense Health Agency Contracting Activity - Dhaca

POSTED

about 1 month ago

DEADLINE

in about 2 months

Data Management and Evaluation SupportThe contract titled Data Management and Evaluation Support is a subcontract under the Administration for Community Living, part of the Department of Health and Human Services, aimed at providing comprehensive support for the collection, management, analysis, and evaluation of research and program outcomes. The work must strictly adhere to federal standards to ensure data integrity, compliance, and quality reporting, with a focus on delivering actionable insights that inform program effectiveness and decision-making. The North American Industry Classification System code 541711 identifies this as scientific research and development services, underscoring the technical and analytical nature of the required efforts. Proposals must be submitted by the deadline of July 29, 2026, with the opportunity posted on June 22, 2026. The place of performance and specific office address are not specified, indicating flexibility in where the work may be conducted, though it must align with federal operational requirements. No set-aside type is designated, meaning the subcontract is open to all eligible subcontractors without preference for small businesses or other categories. Interested parties should review the official solicitation link for detailed submission guidelines and technical requirements, as success will depend on demonstrating robust methodologies in data handling, analytical rigor, and compliance with federal regulations governing research and program evaluation.

Administration For Community Living

POSTED

about 1 month ago

DEADLINE

Collaborative Research Partnership (Partnering PI Option)This contract establishes a collaborative research partnership where a Partnering Principal Investigator from an external institution will co-lead the research effort alongside the primary team, sharing equal responsibility for scientific direction, project management, and deliverables. Funding is jointly allocated between the participating institutions, ensuring aligned resources and mutual accountability for outcomes, with the work focused on health-related research under the Defense Health Agency Contracting Activity. The initiative falls under NAICS code 541711, indicating it is within the scientific research and development sector, and is structured as a subcontract to support integrated, multi-institutional innovation. The opportunity was posted on June 18, 2026, with a deadline for responses set for September 28, 2026, providing potential partners a defined window to submit proposals. The partnership is expected to be conducted in alignment with the mission of the Department of Defense, addressing critical health priorities through joint scientific leadership. There is no set-aside designation specified, meaning eligibility is open to qualified institutions regardless of size or status, and no specific location is designated for performance, allowing flexibility in where the research activities are carried out as long as the objectives are met collaboratively.

Defense Health Agency Contracting Activity - Dhaca

POSTED

about 1 month ago

DEADLINE

Kidney Cancer Clinical Research ExecutionThe contract titled Kidney Cancer Clinical Research Execution aims to advance clinical and translational research focused on kidney cancer through comprehensive scientific activities including study design, patient data collection, biomarker analysis, and therapeutic development. The work is intended to support the development of innovative treatments and diagnostic strategies by integrating clinical observations with laboratory research, ensuring findings are rapidly translated into improved patient outcomes. The project requires expertise in oncology research methodologies, rigorous data management, and interdisciplinary collaboration to address critical gaps in kidney cancer understanding and care. This subcontract is issued by the Defense Health Agency Contracting Activity under the Department of Defense and falls under NAICS code 541711, indicating it is related to research and development in the life sciences. The opportunity was posted on June 18, 2026, with a response deadline of September 28, 2026, providing potential applicants approximately three months to prepare and submit proposals. The place of performance and specific office address details are not specified, suggesting flexibility in location but requiring proposers to align with the overarching objectives of the Department of Defense’s medical research priorities. All work must demonstrate scientific excellence, feasibility, and direct relevance to advancing kidney cancer therapeutics within a clinical context.

Defense Health Agency Contracting Activity - Dhaca

POSTED

about 1 month ago

DEADLINE

Clinical Trial Design and Biostatistical SupportThe contract seeks specialized expertise to support clinical trial design and biostatistical analysis for orthopaedic trauma research funded by the Department of Defense, specifically under the U.S. Army Medical Research and Acquisition Activity. The work involves developing robust clinical trial methodologies, crafting statistical analysis plans, performing power analyses to ensure adequate sample sizes, and establishing data monitoring frameworks to ensure trial integrity and compliance with regulatory standards. Support must be tailored to the unique challenges of military-relevant trauma studies, including patient populations, deployment-related injuries, and the operational constraints of DoD medical settings. The opportunity is structured as a subcontract with a NAICS code of 541711, indicating it falls under research and development in the physical, engineering, and life sciences. The solicitation was posted on June 17, 2026, and responses are due by November 18, 2026. Performance is expected to occur within the broader DoD infrastructure, though no specific location is designated. There is no set-aside classification specified, and the contract is open to qualified entities capable of delivering high-level biostatistical and clinical trial methodological support in a defense medical research context.

Department Of The Army -- Usamraa

POSTED

about 1 month ago

DEADLINE

Nanobody-Drug Conjugate Systems DevelopmentThe contract pertains to the licensing of the NanoFET platform to develop targeted nanobody-drug conjugates for the precision delivery of therapeutics using a modular scaffold designed to enhance specificity and efficiency in therapeutic distribution. This subcontract, issued by the Department of Energy through its contractor Triad, enables the recipient to leverage the proprietary NanoFET technology for advancing next-generation drug delivery systems with a focus on oncology and other targeted disease treatments. The project is centered in Los Alamos, New Mexico, with a response deadline of December 18, 2026, and falls under the NAICS code 541711 for research and development in biotechnology. The modular scaffold allows for customizable conjugation of nanobodies with therapeutic payloads, facilitating high-affinity targeting of disease markers while minimizing off-target effects. The agreement emphasizes technological innovation and the translation of advanced nanoscale platforms into clinically viable delivery systems.

Triad - DOE Contractor

POSTED

about 1 month ago

DEADLINE

Infectious Disease Vaccine DevelopmentThe contract involves licensing the NanoFET platform to enable rapid-response vaccine development against viral and bacterial pathogens, leveraging its unique adjuvant-free immune activation and modular antigen integration capabilities. This technology allows for swift adaptation to emerging infectious threats by streamlining the design and production of vaccines without relying on traditional immune-stimulating additives, significantly reducing development timelines and enhancing safety profiles. The work is structured as a subcontract under the Department of Energy, with performance centered at Los Alamos, New Mexico, and is targeted toward advancing national defense and public health preparedness through next-generation vaccine platforms. The opportunity is open for proposals until December 18, 2026, and falls under NAICS code 541711, indicating it targets research and development in the physical, engineering, and life sciences. The contracting entity is Triad, the DOE Contractor, and the initiative aligns with broader federal efforts to build resilient, scalable biodefense capabilities. Participants must demonstrate technical proficiency in the NanoFET platform, experience in infectious disease vaccine design, and the capacity to execute rapid development cycles under strict timelines. Success in this effort will contribute directly to scalable, next-generation immunization technologies capable of addressing current and future biological threats.

Triad - DOE Contractor

POSTED

about 1 month ago

DEADLINE

Modular Cancer Immunotherapy DevelopmentThe contract entails the license and development of the NanoFET platform for the creation of targeted cancer immunotherapies, leveraging its modular scaffold to deliver tumor-specific antigens and immune stimulators in a precise and effective manner. The work is focused on advancing next-generation immunotherapeutic approaches by engineering the platform to enhance immune recognition and response against cancer cells, with the goal of improving therapeutic outcomes and reducing off-target effects. The project requires collaboration to optimize the platform’s design, validate its efficacy in preclinical models, and prepare for subsequent clinical translation, all grounded in cutting-edge nanotechnology and immunological science. The contract is a subcontract under the Department of Energy, with performance centered in Los Alamos, New Mexico, 87545, and is classified under NAICS code 541711 for research and development in the physical, engineering, and life sciences. The solicitation was posted on June 17, 2026, with a response deadline of December 18, 2026, indicating a strategic timeline for proposal submission and evaluation. While details on set-aside status and point of contact are not provided, the project is positioned to align with national priorities in advanced biomedical innovation and cancer treatment, leveraging federal research infrastructure and expertise to drive transformative therapeutic solutions.

Triad - DOE Contractor

POSTED

about 1 month ago

DEADLINE

Antibody Development & LicensingThe contract involves the development, validation, and commercialization of monoclonal antibodies that specifically target bacterial membrane lipids. This work utilizes a nanodisc platform, which serves either as an immunogen or a screening tool, to enhance the effectiveness of antibody generation and assessment. The effort is positioned as a subcontract under the Department of Energy's Triad contractor, emphasizing a focus on innovative biotechnological approaches within a government research context. Work will be performed in Los Alamos, with the solicitation posted in mid-2026 and a response deadline toward the end of that year. The contract falls under NAICS code 541711, indicating its alignment with research and development in the physical, engineering, and life sciences. Although specific organizational and contact details are not provided, the contract is geared toward advancing antibody technologies through a combination of advanced immunological platforms and commercial application strategies.

Triad - DOE Contractor

POSTED

about 1 month ago

DEADLINE

Preclinical Research & Immunogenicity TestingThe contract involves the execution of binding assays, immune stimulation studies, and antigen identification leveraging the nanodisc platform, aimed at advancing vaccine or therapeutic development. This subcontract, titled "Preclinical Research & Immunogenicity Testing," is to support work primarily focused on preclinical stages of research, targeting immune responses and antigen characterization to facilitate the creation of effective medical interventions. Issued by the Department of Energy through its contractor Triad, the work is to be performed in Los Alamos, with a deadline for responses by mid-December 2026. Classified under NAICS code 541711, which pertains to research and development in biotechnology, the contract does not specify any particular set-aside requirements or organization type constraints. The research efforts under this agreement are expected to play a critical role in underpinning DOE-supported vaccine and therapeutic programs, emphasizing innovative assay platforms like nanodiscs to enhance scientific understanding and product development.

Triad - DOE Contractor

POSTED

about 1 month ago

DEADLINE

More opportunities from Department Of Defense → Department Of The Army -- Usamraa

Same awarding agency

DoW Parkinson’s, Early Investigator Research AwardThe Fiscal Year 2026 Parkinson’s Research Program Early Investigator Research Award supports early-career researchers pursuing innovative, high-impact studies aimed at decreasing risk, slowing progression, or easing symptoms of Parkinson’s disease, with a specific focus on reducing its burden on Service Members, Veterans, and military beneficiaries. Applicants must propose research addressing at least one of four designated focus areas: Clinical and Biological Heterogeneity, Model Systems, or Mechanisms and Biomarkers—including non-motor symptoms such as autonomic, cognitive, fatigue, olfaction, and pain. The award is offered at two funding levels: Level 1 provides up to $300,000 for fellow-level investigators who must be mentored by an experienced PD researcher with a demonstrated record of funding, publications, and mentorship success; Level 2 offers up to $1 million for early-career independent investigators and does not require a mentor. Preliminary data are encouraged but not required for Level 1, while they are mandatory for Level 2. Clinical trials are strictly prohibited. Applications must be submitted via eBRAP for federal entities or Grants.gov for extramural applicants, with a deadline of November 6, 2026. Required attachments include a Project Narrative, Statement of Work with clearly defined annual milestones, a Research Outcomes Plan, a Researcher Development Plan, and other documentation based on the nature of the research, such as Human Subjects or Animal Research Plans. All applications must include representations completed via Grants.gov and active registrations in SAM.gov, eBRAP.org, and Grants.gov, along with a Unique Entity Identifier. Indirect costs must follow the institution’s negotiated rate, and subaward costs are included within the primary award’s direct cost limit. Travel funding is permitted for one investigator to attend one scientific meeting per year in support of multi-institutional collaboration. Awards will be made no later than September 30, 2027, with funds available for obligation through September 30, 2032, and the maximum period of performance is two years. The selection process involves a two-tier review: an initial peer evaluation of the PI’s potential, budget adequacy, scientific environment, data sharing plan, and application clarity—each weighted equally—followed by a programmatic assessment evaluating alignment with PRP priorities, military health impact, and portfolio balance. Applicants must not propose classified research or outcomes, and all foreign affiliations of key personnel must be disclosed; failure to do so will disqualify the

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

about 1 month ago

DEADLINE

DoW Parkinson’s, Investigator-Initiated Research AwardThe FY26 Parkinson’s Research Program Investigator-Initiated Research Award supports high-impact, multidisciplinary research projects that address at least one of the four designated focus areas: Biological and Clinical Heterogeneity, Model Systems, Mechanisms and Biomarkers, and Therapeutic Development. Applications must include preliminary data and are permitted to include clinical trials. The program allows for a Partnering Principal Investigator option, permitting up to two Partnering PIs alongside one Initiating PI, with a combined budget cap of $2 million over the project period. The maximum award duration is three years, and funding is contingent on federal availability, application quality, programmatic relevance, and portfolio balance. All applicants must maintain an active SAM.gov registration with a valid Unique Entity Identifier and submit required representations, particularly for Grants.gov submissions. Research must be aligned with the intent to benefit Service Members, their families, Veterans, and the general public by advancing understanding of Parkinson’s disease, reducing risk, slowing progression, or alleviating symptoms. Submission requires a two-step process: a one-page Letter of Intent via eBRAP followed by a full application through either eBRAP (for intramural DOD organizations) or Grants.gov (for extramural applicants). Full applications must include thirteen specific attachments uploaded as individual PDFs, including a 12-page Project Narrative, a three-page Statement of Work detailing feasible milestones and timelines, Technical and Lay Abstracts, a Research Team Statement, Impact Statement, Post-Award Transition Plan, and mandatory documentation for human subjects, animal research, and clinical trials if applicable. Budgets must be submitted separately for each PI with clear justifications, and indirect costs must align with negotiated institutional rates. Travel costs are restricted to one annual meeting per PI, and all subaward costs are included in the primary award’s direct costs. Applications are reviewed through a two-tier process: peer evaluation on equal-weight criteria including research strategy, budget, environment, data sharing, and presentation, followed by programmatic review assessing alignment with FY26 PRP priorities. Foreign affiliation disclosures for all key personnel are mandatory, and failure to comply results in disqualification. Award recipients must also provide a quad chart and a DoD-compliant data management plan if selected for funding.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

about 1 month ago

DEADLINE

DoW Kidney Cancer, Academy of Kidney Cancer Investigators – Early-Career Scholar AwardThe Kidney Cancer Research Program’s Academy of Kidney Cancer Investigators Early-Career Scholar Award is a competitive research funding opportunity aimed at fostering the next generation of independent kidney cancer investigators. Administered by the Department of Defense through the Defense Health Agency Contracting Activity, this grant supports junior faculty members by pairing them with established mentors who have demonstrated success in both kidney cancer research and mentorship. The program emphasizes not only the scientific merit of proposed research but also the candidate’s potential for long-term career development in the field. Applications must include a detailed project narrative, career development plan, impact statement, and a statement of work with a statistical plan and clearly defined milestones. Preliminary data is required but need not originate from kidney cancer research, allowing for innovative cross-disciplinary approaches. The award provides up to $1.2 million in total costs over a maximum four-year period, with allowable indirect costs based on the institution’s negotiated rate, and all subaward expenses must be included within the primary award’s direct costs. Applicants must be registered in SAM.gov, eBRAP.org, and Grants.gov and must submit a pre-application via eBRAP followed by a full application through either eBRAP (for intramural entities) or Grants.gov (for extramural organizations), with all required attachments in specified formats and filenames. A two-tier review process evaluates technical merit through peer review and programmatic relevance, including alignment with FY26 KCRP focus areas such as basic biology, detection, rare kidney cancers, and novel therapies. Key evaluation priorities include the scholar’s trajectory toward independence and the potential impact of the research on eliminating kidney cancer, particularly in addressing health disparities. Mandatory participation in biennial and annual KCRP-sponsored workshops is required, and recipients must comply with DoDGARs, data management requirements under DoD Instruction 3200.12, and disclose all foreign affiliations of key personnel. Organizations with federal awards exceeding $10 million must report civil, criminal, or administrative proceedings semiannually. Failure to meet deadlines, submit complete documentation, or comply with integrity and registration requirements will result in rejection without exception.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

about 1 month ago

DEADLINE

DoW Kidney Cancer, Idea Development AwardThe fiscal year 2026 Kidney Cancer Research Program Idea Development Award supports high-impact research aimed at advancing the understanding of kidney cancer biology, identifying novel therapeutic strategies, and improving patient outcomes through innovative and testable hypotheses grounded in strong scientific rationale. Applicants must propose a well-developed research approach led by a team with demonstrated expertise in kidney cancer research, and projects must align with one or more focus areas including basic biology, detection and diagnosis, rare kidney cancers, therapeutic strategies, or quality of life improvements. The award offers two submission pathways: a Single Principal Investigator option with a funding cap of $900,000 and a Partnering Principal Investigator option allowing collaboration between two investigators with a combined cap of $1.2 million. For the partnering option, both investigators must submit full applications, with the Partnering PI submitting an abbreviated package specific to their portion of the research; failure to submit either application or administrative withdrawal of either will result in the withdrawal of the entire project. The maximum period of performance is three years, and applicants may request the full funding amount even if the project duration is shorter. Indirect costs must follow negotiated rates, and all subaward costs must be included within the primary award’s direct costs. Applications must be submitted through a two-step process: a pre-application via eBRAP by September 14, 2026, followed by a full application submitted by September 28, 2026, at 11:59 p.m. ET through either eBRAP or Grants.gov depending on the applicant’s institutional type. Extramural organizations must use Grants.gov and hold active SAM.gov, eBRAP.org, and Grants.gov registrations with a valid UEI. Required attachments include a Project Narrative, Technical and Lay Abstracts, Statement of Work, Impact Statement, and, if applicable, an Animal Research Plan, Partnership Statement, and Post-Award Progression Plan. Biographical sketches and current/pending support documents for all key personnel are mandatory, along with the Required Representations document for Grants.gov submissions. Proposals are evaluated based on three equally weighted criteria: research strategy and feasibility, personnel expertise (including collaboration quality), and application presentation and clarity. Additional programmatic review considers alignment with FY26 KCRP priorities, portfolio balance, and relative impact. Award recipients must comply with federal regulations for human subjects and animal research, obtaining approval from the DHA R&D Office of Research and Regulatory Compliance in addition to local IRB or I

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

about 1 month ago

DEADLINE

Travel Coordination for Multi-Institutional CollaborationThe contract establishes a subcontract to manage travel logistics for up to three investigators annually to attend one scientific meeting per year, with allowable direct costs covered under the associated grant. This arrangement supports multi-institutional collaboration by ensuring coordinated, compliant, and efficient travel arrangements for key personnel involved in federally funded research. The work is classified under NAICS code 561510, indicating it involves travel arrangement and related services, and is administered by the Department of the Army through the U.S. Army Medical Research and Acquisition Activity under the broader Department of Defense. The opportunity was posted on June 17, 2026, with a response deadline of November 18, 2026, allowing interested parties sufficient time to prepare proposals. While no specific location of performance or point of contact is provided, the contract is intended to facilitate participation in scientific meetings critical to the advancement of research goals under the grant. The subcontract is not subject to any set-aside requirements and must adhere strictly to federal grant guidelines regarding allowable travel expenses. All logistics must be handled with transparency, cost-effectiveness, and alignment with the sponsor's mission to promote collaborative scientific progress.

Travel Agencies

POSTED

about 1 month ago

DEADLINE

Dissemination and Knowledge Translation ServicesThe contract seeks to develop and execute a strategic plan for disseminating research findings to scientific, clinical, and patient communities through publications, conference presentations, and digital content platforms. The work is classified as a subcontract under NAICS code 541990, indicating it falls under other professional, scientific, and technical services, and is being managed by the Department of the Army through the U.S. Army Medical Research and Acquisition Activity, under the broader Department of Defense. The goal is to ensure that research outcomes reach diverse audiences effectively, promoting translation of scientific knowledge into practical applications and informed decision-making. The opportunity was posted on June 17, 2026, with a response deadline of November 18, 2026, and does not specify a set-aside status or detailed location for performance. All activities must align with the mission of advancing public health and medical science through targeted communication strategies tailored to different stakeholder groups.

All Other Professional, Scientific, and Technical Services

POSTED

about 1 month ago

DEADLINE

Patient Advocacy and Community Engagement CoordinationThe contract seeks to establish and manage partnerships between researchers and patient advocacy groups to enhance collaboration in health-related initiatives, with a focus on building sustainable community engagement structures and actionable engagement plans. It emphasizes the development of frameworks that ensure meaningful involvement of patient communities in research processes, aiming to align scientific objectives with real-world patient needs and perspectives. The effort is designed to foster trust, improve communication, and integrate community input into the design and implementation of research activities under the purview of the Department of Defense. This subcontract, issued under NAICS code 813930 by the Department of the Army through USAMRAA, is open for responses until November 18, 2026, with no specific set-aside provisions indicated. The work does not specify a physical place of performance, suggesting flexibility in execution, potentially across multiple locations or virtually. The initiative is part of broader efforts within the Department of Defense to strengthen public health relationships and ensure that research outcomes are both scientifically rigorous and socially resonant. Participation requires demonstrated expertise in bridging academic research with community advocacy, and the ability to create scalable, inclusive engagement models that empower patient voices throughout the research lifecycle.

Labor Unions and Similar Labor Organizations

POSTED

about 1 month ago

DEADLINE

Scientific Peer Review and Grant Evaluation ServicesThe contract entails providing scientific peer review and grant evaluation services for the Department of the Army through USAMRAA, focusing on the thorough assessment of grant applications across key domains including scientific impact, personnel qualifications, research approach, and the integration of patient advocacy. Evaluators are expected to apply rigorous, evidence-based standards to determine the quality and potential of proposed projects, ensuring alignment with organizational priorities and the advancement of mission-critical health and medical research. The work demands expertise in biomedical and clinical sciences, as well as a demonstrated ability to evaluate the meaningful incorporation of patient perspectives into study design and implementation. This subcontract is open for responses until November 18, 2026, and falls under the NAICS code 541690 for other scientific and technical consulting services. While the solicitation number and point of contact are not specified, the opportunity is posted under the Department of Defense and requires contractors to be prepared for federal grant review protocols. The place of performance and office address details are undefined, suggesting that the work may be performed remotely or across multiple locations, with evaluation tasks managed electronically through the Grants.gov portal. Participation requires a strong background in peer review processes and familiarity with the standards of scientific merit and translational relevance in federally funded research.

Other Scientific and Technical Consulting Services

POSTED

about 1 month ago

DEADLINE

Regulatory Compliance and Ethics Review SupportThe contract seeks a subcontractor to provide comprehensive regulatory compliance and ethics review support for research activities under the Department of Defense, specifically focusing on submissions to Institutional Review Boards, Institutional Animal Care and Use Committees, and other ethics review bodies. The primary responsibility includes ensuring all research protocols adhere to Department of Defense regulations and secure necessary approvals, particularly from the Defense Health Agency Office of Research Oversight and Regulatory Compliance. This work requires deep expertise in navigating federal research ethics frameworks and maintaining strict adherence to DoD standards throughout the lifecycle of research projects. The subcontract is open for proposals with a response deadline of November 18, 2026, and is classified under NAICS code 541611, indicating it pertains to management, scientific, and technical consulting services. The work is associated with the U.S. Army Medical Research and Acquisition Activity under the Department of Defense, though no specific location is designated for performance. The nature of the contract implies that the selected entity will serve in a critical advisory and compliance role, supporting the integrity and legal standing of military-funded research by managing documentation, coordination, and regulatory alignment across multiple oversight entities. No set-aside provisions are in place, making eligibility open to all qualified parties regardless of business size or ownership category.

Administrative Management and General Management Consulting Services

POSTED

about 1 month ago

DEADLINE

Biospecimen Repository and Management ServicesThe contract titled Biospecimen Repository and Management Services aims to establish and maintain secure, high-quality repositories for biospecimens including tissue and blood samples, specifically to support rare cancer research. These repositories must be accurately linked to comprehensive clinical data to enable meaningful analysis and advance scientific understanding of uncommon cancers. The work involves the end-to-end management of specimen collection, processing, storage, and retrieval under strict regulatory and quality standards to ensure data integrity and sample viability over time. The subcontract will require robust infrastructure and protocols for tracking, documentation, and compliance with ethical and privacy guidelines applicable to human biospecimens. The opportunity is posted by the Department of the Army through the U.S. Army Medical Research and Acquisition Activity under the Department of Defense and is classified under NAICS code 541611 for scientific research and development services. It was published on June 17, 2026, with a response deadline of November 18, 2026. The contract is structured as a subcontract and does not specify any set-aside categories or geographic restrictions for performance. While the exact location of performance and point of contact are not provided, the work is expected to support federal research priorities in oncology and may involve collaboration with clinical and research institutions. Interested parties must submit proposals prior to the deadline to be considered for award.

Administrative Management and General Management Consulting Services

POSTED

about 1 month ago

DEADLINE

Rare Cancer Research Data Platform DevelopmentThe contract seeks the design and implementation of technical and organizational platforms dedicated to the collection, sharing, and analysis of rare cancer clinical and preclinical datasets. It is issued as a subcontract under the Department of the Army through USAMRAA, with the NAICS code 541715 indicating it falls under research and development in the biological sciences. The goal is to establish a robust infrastructure that enables secure, standardized, and interoperable handling of complex cancer data across research institutions, supporting accelerated discovery and collaboration in oncology research. The platform must integrate advanced data management protocols, ensure compliance with data privacy and security standards, and facilitate analytical capabilities tailored to the unique challenges of rare cancer datasets. The opportunity was posted on June 17, 2026, with a response deadline of November 18, 2026. There is no specified set-aside designation or geographic restriction for performance, and no point of contact details are provided in the solicitation. The work is expected to require expertise in bioinformatics, data governance, cloud-based infrastructure, and clinical research systems, with a focus on interoperability and scalability. The absence of a place of performance assignment suggests the project may involve distributed collaboration across multiple locations or remote delivery. Interested parties must respond by the deadline to be considered for this subcontract under the Department of Defense’s broader mission to advance rare cancer research through data-driven innovation.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

about 1 month ago

DEADLINE

Regulatory & Compliance Consulting for DoD-Funded ResearchThe contract seeks expert consulting services to ensure full regulatory compliance for research funded by the Department of Defense, with a focus on intricate processes such as Institutional Review Board and Institutional Animal Care and Use Committee submissions, disclosures required under National Security Presidential Memorandum 33, and adherence to the Department of Defense Grant and Agreement Regulations. The scope centers on providing specialized guidance to navigate complex federal requirements, helping recipients maintain legal and ethical standards while advancing federally supported research initiatives. The contract is structured as a subcontract under the Department of the Army through USAMRAA, operating within the broader Department of Defense framework, and is aligned with NAICS code 541611 for management consulting services. The posting date is June 17, 2026, with responses due by September 16, 2026. While the place of performance and specific point of contact details are not provided, the work is anticipated to support DoD-funded projects requiring stringent oversight and documentation, emphasizing proactive compliance and risk mitigation in sensitive research environments.

Administrative Management and General Management Consulting Services

POSTED

about 1 month ago

DEADLINE

in about 2 months